Studies have shown that the levels of bile acids and ALT are elevated in patients with T2DM-associated NAFLD and that the levels of secondary bile acids can increase in patients with NAFLD (90, 91). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.